Details

NameSymbolSector
PIRAMAL PHARMA LIMITEDPPLPHARMAPharmaceuticals
Open
170
High
171.47
Low
163.5
Close
164.47
Volume
6015652
Exchange
nse
Time
28-Apr-2026

Outlook

Score:  

2.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Piramal Pharma is  
Engulfing
Estimated Stoploss of Piramal Pharma is ₹  
171.47
Piramal Pharma has a  
Bearishℹ
 pattern. 
Formation of  
Engulfing
 candle pattern indicates Piramal Pharma has chances of  
Reversalℹ
 to down trend 

Trend

Piramal Pharma is in  
Uptrendℹ
. 
Price of Piramal Pharma is  
Upℹ
 by  

9.95

%. 
Target
Buy @ 

153.3

Sell @ 

167.9

Current @ 

164.47

Volume

The trade volume of Piramal Pharma has been  
Goodℹ
Though the volume trend for Piramal Pharma appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Piramal Pharma is  

Up

 by  

42.2

% 

Valuation

The current market price of Piramal Pharma is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 15677cr and total assets worth ₹ 15677cr, the balance sheet of Piramal Pharma is:  
Balancedℹ
. 
Cashflow
Piramal Pharma has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 36cr

. It is  
Downℹ
 by  

121.82

%. 

(*Mar 2025)

49.04% i.e. ₹ 892cr earned in operatingℹ
26.22% i.e. ₹ 477cr spent in investingℹ
24.19% i.e. ₹ 440cr spent in financingℹ
0.55% i.e. ₹ 10cr spent in otherℹ
Piramal Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 165cr

. It is  
Upℹ
 by  

632.26

%. 

(*Mar 2024)

53.49% i.e. ₹ 1004cr earned in operatingℹ
23.12% i.e. ₹ 434cr spent in investingℹ
22.48% i.e. ₹ 422cr spent in financingℹ
0.91% i.e. ₹ 17cr earned in otherℹ
Income
The income of Piramal Pharma is  

₹ 2109cr

 and  

Loss

 is :  

₹ 114cr

(*Sep 2025)

Piramal Pharma Losses increased by:  

172.99

% and Income is Down by:  

28.76

% 

(*Sep 2025)

The income of Piramal Pharma is  

₹ 1992cr

 and  

Profit

 is :  

₹ 100cr

(*Jun 2025)

Piramal Pharma Profit is up by:  

1153.85

% and Income is Up by:  

26.17

% 

(*Jun 2025)

The income of Piramal Pharma is  

₹ 2796cr

 and  

Loss

 is :  

₹ 137cr

(*Mar 2025)

Piramal Pharma Losses increased by:  

360

% and Income is Down by:  

3.74

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.